A Hybrid Breast Cancer/Mesenchymal Stem Cell Population Enhances Chemoresistance and Metastasis

The authors showed that clinical samples of primary invasive carcinoma and chemoresistant breast cancer metastasis contain a unique hybrid cancer cell population coexpressing pancytokeratin and the MSC marker fibroblast activation protein-α.